Repatha® is an injectable prescription medicine used:
To use your co-pay card, follow these 3 simple steps
This is your personal co-pay card information:
If you have any questions, please contact 1-844-REPATHA (1-844-737-2842).
*Eligibility criteria and program maximums apply. See full Terms and Conditions at Terms and Conditions.
*Eligibility criteria and program maximums apply. See full Terms and Conditions at repatha.com/copaytcs.
…and the process of getting insurance approval has improved.
Examples of commercial insurance include PPO, HMO, or COBRA. What you pay for Repatha® will vary depending on your insurance plan.
~82% of commercial prescriptions of Repatha costs $49 or less*
With the Repatha® Co-Pay Card, eligible commercially insured patients may pay as little as $15 per month.†
*Data on file, Amgen; 2024. Based on IQVIA claims data from 1/1/2023 to 12/31/23 using commercial (including commercially insured patients with the Repatha® Co-Pay Card), Medicare, and Medicaid claims.
†Program maximums and Terms and Conditions apply. See full Terms and Conditions at Repatha.com/copaytcs
~71% of Medicare prescriptions for Repatha® cost patients $49 or less per month.1,*
If you have Medicare Part D coverage and are eligible for Part D Low Income Subsidy, you can expect to pay $10.35 per month.2,‡
If you are unsure whether you qualify for Extra Help and would like more information, please visit
www.ssa.gov/benefits/medicare/prescriptionhelp/.
*Based on IQVIA claims data from 1/1/2022 to 12/31/2022.
‡Your out-of-pocket costs can vary throughout the year depending on which phase of the Part D benefit you are currently in. Medicare Part D drug coverage is divided into four phases, each with a different cost-sharing amount. Those phases are 1) Deductible, 2) Initial coverage, 3) Coverage gap, and 4) Catastrophic.
99% of Medicaid prescriptions for Repatha® cost patients $10 or less per month.§,1
To find out if you qualify for Medicaid, or for more information about copayments in your state, please visit:
www.medicaid.gov/state-overviews/index.html.
§Based on IQVIA claims data from 1/1/2022 to 12/31/2022.
Amgen® SupportPlus can provide your patients with information about independent nonprofit foundations that may be able to help.* Call Amgen® SupportPlus at 1-844-REPATHA to learn more.
*Eligibility for resources provided by independent nonprofit patient assistance programs is based on the nonprofit’s criteria. Amgen has no control over these programs and provides information as a courtesy only.
We know every patient has unique needs. And we’re here to provide financial support information and resources, regardless of their current financial situation or type of insurance they have. Call an Amgen® SupportPlus Representative at (1-844-737-2842) from Monday - Friday 8AM - 8PM EST to learn more.
*Covered includes Covered, Covered (PA/ST), Preferred, and Preferred (PA/ST) as defined by Managed Markets Insights and Technology (MMIT) data. Number of commercially insured lives provided is obtained from MMIT for commercial health plans in the United States as of August 2024.
†Covered includes Covered, Covered (PA/ST), Preferred, and Preferred (PA/ST) as defined by Managed Markets Insights and Technology (MMIT) data. Number of Medicare lives provided is obtained from MMIT for Medicare health plans in the United States as of August 2024.
‡Based on IQVIA claims data from 1/1/2023 to 12/31/2023. This information is subject to change without notice. For the most up-to-date and complete information regarding coverage of Repatha®, please contact the relevant payer directly.
References: 1.Data on file, Amgen; [1]; 2024. 2. Data on file, Amgen; [2]; 2024. 3. Data on file, Amgen; [3]; 2024.Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.
Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Repatha® is available as prefilled single-dose SureClick® autoinjectors and prefilled single-dose syringes that either contain dry natural rubber (a derivative of latex) in the needle cover or are not made with natural rubber latex. The carton and "Instructions for Use" will state if your prefilled single-dose SureClick® autoinjector or prefilled single-dose syringe contains dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex.
Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take.
What are the possible side effects of Repatha®?
Repatha® can cause serious side effects including serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.
The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes) and redness, pain, or bruising at the injection site.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
What is Repatha®?
Repatha® is an injectable prescription medicine used:
Please see full Prescribing Information, including Patient Product Information.
Important Safety Information
Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.